SCHEMBL4989915

SCHEMBL4989915

Cc1ccc(-c2nc(C(=O)NC(C)(C)C)nn2-c2cccnc2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2A6 P11509 1/20 0.42
CNR1 P21554 3/20 0.41
CNR2 P34972 3/20 0.41
KDM4E B2RXH2 4/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RIPK1 Q13546 1/20 0.36
ESR1 P03372 1/20 0.36
SYK P43405 3/20 0.36
ALDH1A1 P00352 3/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK13 O15264 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988249 0.88 KMT2A (0.46) KMT2ACYP2A6CNR1CNR2KDM4E
SCHEMBL4986649 0.87 SYK (0.36) KDM4EMAPTNPSR1HPGDSMN1; SMN2
SCHEMBL4987010 0.85 SMN1; SMN2 (0.48) KMT2ACYP3A4CYP2A6KDM4EMAPT
SCHEMBL5522031 0.82 CNR1 (0.52) KMT2ACYP3A4CYP2A6CNR1CNR2
SCHEMBL27699823 0.82 KMT2A (0.47) KMT2ACYP3A4CYP2A6KDM4EHPGD
SCHEMBL4990555 0.82 MEN1 (0.38) KMT2ASMN1; SMN2SYK
SCHEMBL4984582 0.78 ATM (0.39) KMT2AKDM4ENPSR1HPGDSMN1; SMN2
SCHEMBL5518588 0.73 CNR1 (0.66) CYP3A4CYP2A6CNR1CNR2
SCHEMBL14186838 0.73 FEN1 (0.42) CNR1KDM4ENPSR1HPGDSMN1; SMN2
SCHEMBL4987004 0.73 KMT2A (0.39) KMT2ACYP3A4CNR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-05-29 US disclosed
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-05-29 US disclosed
EP-1803719-A1 1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative PTGS1, PTGER1, TBXA2R KMT2A 3245/4885CYP3A4 565/4885CYP2A6 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.